{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:39:34Z","timestamp":1795045174279,"version":"4.10.2"},"reference-count":46,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypoxia-inducible factor-1\u03b1 (HIF1\u03b1), a master transcriptional regulator of the cellular and systemic hypoxia response, is essential for the maintenance of self-renewal capacity of normal HSCs. It is still unknown whether HIF1\u03b1 has a role in survival regulation of leukemia stem cells (LSCs) in chronic myeloid leukemia (CML). Using a mouse model of CML, here we report that HIF1\u03b1 plays a crucial role in survival maintenance of LSCs. Deletion of HIF1\u03b1 impairs the propagation of CML through impairing cell-cycle progression and inducing apoptosis of LSCs. Deletion of HIF1\u03b1 results in elevated expression of p16Ink4a and p19Arf in LSCs, and knockdown of p16Ink4a and p19Arf rescues the defective colony-forming ability of HIF1\u03b1\u2212\/\u2212 LSCs. Compared with normal HSCs, LSCs appear to be more dependent on the HIF1\u03b1 pathway. Together, these results demonstrate that HIF1\u03b1 represents a critical pathway in LSCs and inhibition of the HIF1\u03b1 pathway provides a therapeutic strategy for eradicating LSCs in CML.<\/jats:p>","DOI":"10.1182\/blood-2011-10-387381","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T01:03:13Z","timestamp":1327453393000},"page":"2595-2607","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":174,"title":["HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells"],"prefix":"10.1182","volume":"119","author":[{"given":"Haojian","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin S.","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Pharmacology; Bioinformatics Core, University of Massachusetts Medical School, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111808054084100_B1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer.","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2019111808054084100_B2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1532\/IJH97.05011","article-title":"Epigenetic regulation of hematopoietic stem cell self-renewal by polycomb group genes.","volume":"81","author":"Iwama","year":"2005","journal-title":"Int J Hematol"},{"key":"2019111808054084100_B3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back.","volume":"22","author":"Wong","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"14","key":"2019111808054084100_B4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111808054084100_B5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"issue":"6937","key":"2019111808054084100_B6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","article-title":"Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.","volume":"423","author":"Lessard","year":"2003","journal-title":"Nature"},{"issue":"7239","key":"2019111808054084100_B7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"issue":"6","key":"2019111808054084100_B8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"issue":"6937","key":"2019111808054084100_B9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"issue":"7","key":"2019111808054084100_B10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","article-title":"Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.","volume":"41","author":"Chen","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"2019111808054084100_B11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.21908","article-title":"The hematopoietic stem cell niche: low in oxygen but a nice place to be.","volume":"222","author":"Eliasson","year":"2010","journal-title":"J Cell Physiol"},{"issue":"2","key":"2019111808054084100_B12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","article-title":"Oxygen in stem cell biology: a critical component of the stem cell niche.","volume":"7","author":"Mohyeldin","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111808054084100_B13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.2004-0351","article-title":"Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells.","volume":"24","author":"Hermitte","year":"2006","journal-title":"Stem Cells"},{"issue":"2","key":"2019111808054084100_B14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress.","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"issue":"4","key":"2019111808054084100_B15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.exphem.2010.01.005","article-title":"Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture.","volume":"38","author":"Eliasson","year":"2010","journal-title":"Exp Hematol"},{"issue":"3","key":"2019111808054084100_B16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells.","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2019111808054084100_B17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy.","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019111808054084100_B18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer.","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"issue":"4","key":"2019111808054084100_B19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrm2354","article-title":"The role of oxygen availability in embryonic development and stem cell function.","volume":"9","author":"Simon","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2019111808054084100_B20","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"2019111808054084100_B21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4161\/cc.10.8.15326","article-title":"HIF-1alpha depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.","volume":"10","author":"Culver","year":"2011","journal-title":"Cell Cycle"},{"key":"2019111808054084100_B22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1476-4598-9-133","article-title":"Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.","volume":"9","author":"Mendez","year":"2010","journal-title":"Mol Cancer"},{"issue":"45","key":"2019111808054084100_B23","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1038\/onc.2009.252","article-title":"Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.","volume":"28","author":"Soeda","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"2019111808054084100_B24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies.","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"9","key":"2019111808054084100_B25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","article-title":"The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.","volume":"189","author":"Li","year":"1999","journal-title":"J Exp Med"},{"issue":"3","key":"2019111808054084100_B26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2009-06-228130","article-title":"PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.","volume":"115","author":"Peng","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111808054084100_B27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.","volume":"36","author":"Hu","year":"2004","journal-title":"Nat Genet"},{"issue":"23","key":"2019111808054084100_B28","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1093\/emboj\/20.23.6793","article-title":"Tyrosine phosphorylation of Grb2 by Bcr\/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.","volume":"20","author":"Li","year":"2001","journal-title":"EMBO J"},{"issue":"43","key":"2019111808054084100_B29","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111808054084100_B30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"45","key":"2019111808054084100_B31","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.","volume":"103","author":"Hu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2019111808054084100_B32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev"},{"issue":"4","key":"2019111808054084100_B33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2004.01.005","article-title":"Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.","volume":"32","author":"Almarza","year":"2004","journal-title":"Exp Hematol"},{"issue":"3","key":"2019111808054084100_B34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1074-7613(00)80316-7","article-title":"Telomerase activity in hematopoietic cells is associated with self-renewal potential.","volume":"5","author":"Morrison","year":"1996","journal-title":"Immunity"},{"issue":"16","key":"2019111808054084100_B35","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.161269798","article-title":"Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.","volume":"98","author":"Loonstra","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7288","key":"2019111808054084100_B36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature08982","article-title":"Linking functional decline of telomeres, mitochondria and stem cells during ageing.","volume":"464","author":"Sahin","year":"2010","journal-title":"Nature"},{"issue":"1","key":"2019111808054084100_B37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans.","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2019111808054084100_B38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"issue":"10","key":"2019111808054084100_B39","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111808054084100_B40","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"issue":"20","key":"2019111808054084100_B41","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"2019111808054084100_B42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/MCB.23.1.359-369.2003","article-title":"Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.","volume":"23","author":"Goda","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2019111808054084100_B43","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/MCB.19.3.1981","article-title":"Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.","volume":"19","author":"McConnell","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2019111808054084100_B44","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20052477","article-title":"Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.","volume":"203","author":"Oguro","year":"2006","journal-title":"J Exp Med"},{"issue":"7240","key":"2019111808054084100_B45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo.","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"issue":"6","key":"2019111808054084100_B46","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.","volume":"15","author":"Sato","year":"2009","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/11\/2595\/1350753\/zh801112002595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/11\/2595\/1350753\/zh801112002595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:22:26Z","timestamp":1574065346000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/11\/2595\/29631\/HIF1%CE%B1-is-required-for-survival-maintenance-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,15]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-387381","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,15]]}}}